April 18, 2014 9:30 PM ET

Biotechnology

Company Overview of Invivoscribe Technologies, Inc.

Company Overview

Invivoscribe Technologies, Inc., together with its subsidiaries, provides PCR-based gene rearrangement, chromosome translocation, and gene mutation research use only testing reagents, assays, and controls. It offers master mixes, DNA and RNA controls, analyte specific reagents, and CE marked assays. The company also offers in vitro diagnostic products to identify, classify, and monitor leukemia, lymphomas, and other lymphoproliferative diseases; and provides services focused on personalized molecular medicine, personalized molecular diagnostics, and biomarker testing. In addition, it offers LabFlow Software, an ERP software package, which helps in managing and coordinating GMP manufacturing ...

6330 Nancy Ridge Drive

Suite 106

San Diego, CA 92121-3230

United States

Founded in 1995

Phone:

858-224-6600

Fax:

858-224-6601

Key Executives for Invivoscribe Technologies, Inc.

Chief Financial Officer
Director of Operations
Director of Regulatory Affairs
Senior Legal Counsel of Special Projects and Director
Compensation as of Fiscal Year 2013.

Similar Private Companies By Industry

Company Name Region
Finnzymes, Inc. United States
Healthpoint, Ltd. United States
Soluble Therapeutics, LLC United States
Origen Therapeutics, Inc. United States
AnaptysBio, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Invivoscribe Technologies, Inc., please visit www.invivoscribe.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.